The proposed programs

AUTOIMMUNITY

Short title
Scheme

Evaluated antibodies Format Order number Time
period
Myasthenia
Autoantibodies in myasthenic diseases
AChR, muscle-specific kinase (MuSK), striated muscles [IgG] 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1435a-0202
QV 1435a-0204-1
2
ANA
Autoantibodies against cell nuclei
Cell nuclei, centromeres, CENP A, CENP B, dsDNA, nucleosomes, ribosomal P protein, RNP/Sm, RNP, Scl-70, Sm, SS-A, SS-B [IgG] 1 set of specimen 2x400µl QV 1510-0204  1
ANCA
Autoantibodies against granulocytes
ANCA, MPO, PR3 [IgG]  1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1200-0202
QV 1200-0204-1
2
CCP
Antibodies against CCP 
CCP [IgG]  1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1505-0202
QV 1505-0204-1 
2
Celiac disease
Antibodies against tissue transglutaminase (endomysium) and gliadin
tTG, EMA, Gliadin
[IgA, IgG] 
1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1913-0202
QV 1913-0204-1
2
Diabetes
Autoantibodies in Diabetes
GAD, Islet cells, IA2, Zinc transporter 8 [IgG] 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1020-0202
QV 1020-0204-1
2
Kidney
Antibodies in autoimmune kidney diseases
GBM, PLA2R, THSD7A [IgG]  1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1250-0202
QV 1250-0204-1
2
Liver
Antibodies in autoimmune liver diseases
AMA, ASMA, F-actin, gp210, LC-1, LKM-1, M2, nuclear dots, nuclear membrane, SLA/LP, Sp100 [IgG, IgAGM] 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1300-0202
QV 1300-0204-1
1
Myopathies
Antibodies in autoimmune Myopathies
cN-1A, EJ, Jo-1, Ku, Mi-2, Mi-2a, Mi-2b, OJ, PL-7, PL-12, PM-Scl, SRP [IgG] 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1530-0202
QV 1530-0204-1
1
Neuronals
Autoantibodies against neuronal antigens
Amphiphysin, Aquaporin 4, CASPR2, CV2, GAD, Hu, LGI1, Ma/Ta, MOG, NMDA receptor, Recoverin, Ri, SOX1, Titin, Yo, Zic4
[IgG, IgAGM]
1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1111-0202
QV 1111-0204-1
2
PA
Autoantibodies in pernicious anaemia
Intrinsic Faktor, Parietalzellen (PCA) [IgG] 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1360-0202
QV 1360-0204-1
2
Phospholipids
Autoantibodies against phospholipids
Cardiolipin [IgG, IgM, IgAGM],
ß2-Glykoprotein [IgG, IgM, IgAGM]
1 set of specimen 2x150µl
2 sets of specimen 2x300µl
QV 1632-0201
QV 1632-0203-1
2
Skin
Autoantibodies against structural proteins of the skin
BP 180, BP 230, collagen type VII, desmoglein 1 and 3, desmosomes, epidermal basement membrane [IgG] 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 1501-0202
QV 1501-0204-1
2
Thyroid gland
Autoantibodies against thyroid gland
TG, TPO, TRAk
[IgG] 
1 set of specimen 2x300µl
2 sets of specimen 2x600µl
QV 1010-0203
QV 1010-0206-1
2
INFECTIOUS SEROLOGY

Short title
Scheme

Evaluated antibodies Format Order number Time
period
Borrelia
Antibodies against Borrelia burgdorferi sensu lato
Borrelia [IgG, IgM],
serological diagnosis
1 set of specimen 2x250µl
2 sets of specimen 2x500µl
QV 2132-0202
QV 2132-0205-1
1
Chikungunya Virus
Antibodies against Chikungunya Virus
Chikungunya-Virus
[IgG, IgM]
1 set of specimen 2x300µl
2 sets of specimen 2x600µl
QV 293a-0203
QV 293a-0206-1
3
Dengue Virus
Antibodies against Dengue-Virus
Dengue virus [IgG, IgM],
Dengue virus NS1 antigen
1 set of specimen 2x300µl
2 sets of specimen 2x600µl
QV 266a-0203
QV 266a-0206-1
3
EBV
Antibodies against Epstein-Barr Virus
EBV-CA [IgG, IgM], EBNA-1 [IgG], avidity, serological diagnosis 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 2790-0202
QV 2790-0204-1
1
HEV
Antibodies against Hepatitis-E Virus
HEV [IgG, IgM, IgAGM] 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 2525-0202
QV 2525-0204-1
1
HSV
Antibodies against Herpes simplex-Virus
HSV 1, HSV 2, HSV-1/2 [IgG, IgM] 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 2531-0202
QV 2531-0204-1
1
Measles virus
Antibodies against measles virus
Measles vius [IgG, IgM] 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 2610-0202
QV 2610-0204-1
1
Parvovirus B19
Antibodies against Parvovirus B19
Parvovirus B 19 [IgG, IgM] 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 2580-0202
QV 2580-0204-1
1
SARS CoV-2
Antibodies against SARS CoV-2
SARS-CoV-2 (NCP), SARS CoV-2 (S1) [IgG], neutralizing antibodies 1 set of specimen 2x200µl
2 sets of specimen 2x400µl
QV 2606-0202
QV 2606-0204-1
1
Zika virus
Antibodies against Zika virus
Zika virus [IgG, IgM, IgA, IgAM] 1 set of specimen 2x300µl
2 sets of specimen 2x600µl
QV 2668-0203
QV 2668-0206-1
3
ALLERGOLOGY

Short title
Scheme

Evaluated antibodies Format Order number Time
period
Molecular allergology
Molecular Allergology specific IgE
Specific IgE (at least 6 different per distribution) 1 set of specimen 2x1000µl QV 3002-0210 4
Specific IgE
Allergology specific IgE
Specific IgE (at least 6 different per distribution) 1 set of specimen 2x1000µl QV 3000-0210 1
Total IgE
Allergology total IgE
Total IgE 1 set of specimen 2x500µl
2 sets of specimen 2x1000µl
QV 3840-0205
QV 3840-0210-1
1
  Deadline for registration/ deregistration Half-year Date of shipment Deadline
Time period 1 November 30, 2024
June 30, 2025
I
II
March 11, 2025
September 9, 2025
April 8, 2025
October 7, 2025
Time period 2 November 30, 2024
June 30, 2025
I
II
April 8, 2025
October 14, 2025
May 6, 2025
November 11, 2025
Time period 3  November 30, 2024 I March 11, 2025 April 8, 2025
Time period 4  June 30, 2025 II September 9, 2025 October 7, 2025